Role of calcimimetics in treating bone and mineral disorders related to chronic kidney disease

HIGHLIGHTS

  • who: Yi-Chou Hou et al. from the Division of Nephrology, Department of Medicine, Cardinal-Tien Hospital, School of Medicine, TMU Research Centre of Urology and Kidney, Taipei Medical University, New Taipei City, Taiwan have published the research work: Role of Calcimimetics in Treating Bone and Mineral Disorders Related to Chronic Kidney Disease, in the Journal: Pharmaceuticals 2022, 952 of 27/07/2022
  • what: CKD-MBD is a severe complication in patients with CKD and ESRD.
  • how: This article presents a review of the pathogenesis of renal osteodystrophy and the pleiotropic effects of . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?